highperformr logo

Roche's Overview

Total employees103613
HeadquartersBasel
Founded1896

Roche Holding AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. The company also has a strong presence in in-vitro diagnostics and is a market leader in this field. Roche is known for its significant investment in research and development, focusing on personalized healthcare and innovative treatments for serious diseases.

Where is Roche's Headquarters?

HQ Function

Global strategic direction, core research and development leadership, corporate governance, and administrative functions for Roche's worldwide operations.

Notable Features:

The Roche Towers (Bau 1 and Bau 2) are iconic modern skyscrapers designed by Herzog & de Meuron, dominating the Basel skyline and reflecting the company's modernity. The campus includes state-of-the-art research labs and historical buildings.

Work Culture:

Roche's Basel headquarters fosters a highly scientific, innovative, and collaborative environment. There's a strong emphasis on research, precision, and a long-term perspective. Employees often describe it as international, with a focus on work-life balance supported by Swiss cultural norms.

HQ Significance:

As the birthplace and global nerve center of Roche, the Basel headquarters is crucial for its strategic decision-making, innovation pipeline, and maintaining its position as a global leader in pharmaceuticals and diagnostics.

Values Reflected in HQ: The headquarters reflects Roche's commitment to innovation (state-of-the-art labs, modern architecture), sustainability (efficient building design), and its long-standing heritage in healthcare.

Location:

Roche supports a wide array of functions globally, including research and development, manufacturing, sales and marketing for its pharmaceuticals and diagnostics divisions, clinical trial operations, regulatory affairs, and extensive customer support services. The company operates in over 100 countries with major R&D and manufacturing sites across North America, Europe, and Asia.

Street Address:

Grenzacherstrasse 124

City:

Basel

State/Province:

Basel-Stadt

Country:

Switzerland

Roche's Global Presence

South San Francisco, California, USA

Address: 1 DNA Way, South San Francisco, CA 94080, USA

Serves as Roche's primary hub for biotech innovation and operations in North America, driving significant portions of its pharmaceutical pipeline.

Penzberg, Germany

Address: Nonnenwald 2, 82377 Penzberg, Germany

Key European hub for integrated research, development, and production across both Roche divisions, significantly contributing to its global supply chain and innovation.

Shanghai, China

Address: Building 5, Lane 1387, Zhang Dong Road, Pudong, Shanghai, China

Drives Roche's growth and innovation in the rapidly expanding Chinese and broader APAC healthcare markets.

Buying Intent Signals for Roche

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Roche

As of April 2025, Roche' leadership includes:

Dr. Severin Schwan - Chairman of the Board of Directors
Dr. Thomas Schinecker - Chief Executive Officer (CEO)
Teresa Graham - CEO Roche Pharmaceuticals
Matt Sause - CEO Roche Diagnostics
Dr. Alan Hippe - Chief Financial and IT Officer
Dr. Levi Garraway - Chief Medical Officer and Head of Global Product Development

Investors of Roche

Roche has been backed by several prominent investors over the years, including:

Hoffmann family pool (descendants of the founder, holding majority voting rights)
Novartis (historically a significant shareholder, though they sold their stake in 2021)
Institutional investors such as BlackRock, The Vanguard Group, Norges Bank Investment Management, and various pension funds (common for publicly traded shares).

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

Roche has seen key leadership transitions, notably with Thomas Schinecker becoming CEO in March 2023, and subsequent appointments for divisional CEO roles.

Departures

Christoph Franz, Christoph Franz stepped down as Chairman, succeeded by Severin Schwan.

New Appointments:

Dr. Thomas Schinecker, Dr. Thomas Schinecker appointed as Group CEO.
Teresa Graham, Teresa Graham appointed as CEO of Roche Pharmaceuticals.
Matt Sause, Matt Sause appointed as CEO of Roche Diagnostics.

Technology (Tech Stack) used by Roche

Discover the tools Roche uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Roche Email Formats and Examples

Roche commonly uses the [first].[last]@roche.com email format for its employees. Variations might exist based on region or department, but this is the most widely recognized pattern.

[first].[last]@roche.com

Format

jane.doe@roche.com

Example

95%

Success rate

News and media

Roche News2024-05-21

Roche’s Alecensa significantly reduced the risk of disease recurrence or death in people with ALK-positive early-stage lung cancer in phase III ALINA study

Roche announced new and updated data from across its oncology portfolio at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Key results from the phase III ALINA study showed Alecensa (alectinib) reduced the risk of disease recurrence or death by an unprecedented 76% compared to platinum-based chemotherapy in people with anaplastic lymphoma kinase (ALK)-positive early-stage non-small cell lung cancer (NSCLC) after tumour resection....more

Roche News2024-04-17

Roche reports good start to 2024

Roche reported solid Q1 2024 results with Group sales increasing by 2% at constant exchange rates. Pharmaceuticals Division sales grew by 2%, driven by newer medicines. Diagnostics Division sales also saw a 2% increase, primarily due to strong immunodiagnostics performance. The company confirmed its outlook for the full year....more

Roche News2024-03-13

Roche to acquire LumiraDx’s Point of Care diagnostics platform technology

Roche announced it has entered into an agreement to acquire select assets related to LumiraDx's Point of Care (PoC) diagnostics platform technology. This acquisition aims to strengthen Roche’s diagnostics portfolio and expand its offerings in the PoC segment, providing healthcare professionals with faster and more convenient testing options....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Roche, are just a search away.